Compound class:
Synthetic organic
Comment: AZ1 is a sulfonyl piperazine compound with antibacterial activity, discovered using a high-throughput phenotypic screen [3]. It is a novel inhibitor of bacterial cell wall synthesis that acts by targeting UDP-2,3-diacylglucosamine hydrolase (LpxH), an enzyme in the lipopolysaccharide synthesis pathway [1]. LpxH is an essential enzyme, conserved in the majority of Gram-negative bacteria but absent in human, and an attractive target for antibacterial development.
|
|
Bioactivity Comments |
An initial study found that although AZ1 lacked activity against most of the Gram-negative and Gram-positive bacteria tested, it did inhibit the growth of an Escherichia coli efflux mutant (W3110 ΔtolC) with a MIC of 0.25μg/ml [3]. AZ1 is also reported to have activity against wild-type Klebsiella pneumoniae [2]. |